呼吁下一代药物消除吸收障碍,以打击抗生素耐药性
Bo Peng1, Hui Li1, Xuan-Xian Peng1
1State Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Guangdong Key Laboratory of Pharmaceutical Functional Genes, Sun Yat-sen University, University City, Guangzhou 510006, People's Republic of China; Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266071, People's Republic of China.
新型基于代谢物的辅助剂可以增强抗生素对抗耐药细菌的疗效. 这种方法将代谢物与现有抗生素结合在一起,为应对抗生素耐药性带来的公共卫生挑战提供了一个有前途的战略.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 抗生素耐药性是一个重大的全球健康威胁,由两代人对现有抗菌剂的细菌不敏感性驱动.
- 抗生素耐药性病原体的出现需要新的治疗策略来克服治疗的局限性.
研究的目的:
- 提出一种以代谢物为基础的方法,作为开发下一代抗菌剂的有希望的战略.
- 解决迫切需要新的策略来打击抗生素耐药的病原体.
主要方法:
- 研究以代谢物为基础的辅助剂,增强抗生素吸收和疗效.
- 将代谢物与现有的抗菌药物结合起来,制造出新的治疗剂.
主要成果:
- 基于代谢物的辅助剂被认为是一种有效的策略,耐药性发展的可能性很低.
- 这种方法可以提高现有的抗生素对抗耐药细菌菌株的疗效.
结论:
- 基于代谢物的方法,结合代谢物和抗菌剂,是开发下一代药物的有希望的策略.
- 这种创新方法提供了一种可行的解决方案,用于对抗抗生素耐药性病原体,并减轻严重的公共卫生挑战.
更多相关视频
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
相关概念视频
Development of Antibiotic Resistance
Antibiotic Selection
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drug Elimination by Renal Route: Tubular Secretion
Gene Regulation in Microbial Communities: Quorum Sensing
